HUNT RONALD — SEC insider filings
SEC reporting owner CIK 1247851. 38 insider filings on record with FilingPulse; latest filed 2026-11-05.
Transaction summary — filings shown
Covers all 38 filings on record, filed 2021-05-07 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 2,096,486 shares, $17,999,994 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 75.
- Largest priced transaction: purchase of 10,000 shares @ $1,000.00 ($10,000,000) in Harpoon Therapeutics, Inc., filed 2023-03-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. (HARP) | Director, 10% owner | 13 | 4 legs · 1,788,794 sh · $13,999,998 | — | 27 |
| Rallybio Corp (RLYB) | Director | 12 | 2 legs · 307,692 sh · $3,999,996 | — | 22 |
| Iterum Therapeutics plc (ITRM) | Director | 13 | — | — | 26 |
Insider filings — HUNT RONALD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 14,305 @ $4.45 · Option exercise (M): 14,305 (derivative) @ $3.60 | EDGAR |
| 2026-11-02 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 9,196 @ $7.60 · Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 9,196 (derivative) @ $5.60 · Option exercise (M): 2,062 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 14,305 (derivative) @ $3.60 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Iterum Therapeutics plc (ITRM) | Other (J) @ $2,208,000 · Other (J) @ $792,000 | EDGAR |
| 2025-01-06 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 73,571 (derivative) @ $0.70 | EDGAR |
| 2024-08-12 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 182,453 · Option exercise (M): 65,481 · Option exercise (M): 364,906 (derivative) @ $0 · Option exercise (M): 182,453 (derivative) · Option exercise (M): 182,453 (derivative) · Option exercise (M): 130,962 (derivative) @ $0 · +2 more | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · +6 more | EDGAR |
| 2024-01-04 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 29,096 (derivative) @ $1.77 | EDGAR |
| 2024-01-03 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 1,072 @ $0 | EDGAR |
| 2023-11-28 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 5,000 @ $0 | EDGAR |
| 2023-10-27 | 4 | Harpoon Therapeutics, Inc. (HARP) | Purchase (P): 1,372,000 · Purchase (P): 171,500 · Purchase (P): 686,000 (derivative) · Purchase (P): 85,750 (derivative) | EDGAR |
| 2023-10-02 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 5,479 · Option exercise (M): 5,479 (derivative) @ $0 | EDGAR |
| 2023-10-02 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 3,035 @ $0 | EDGAR |
| 2023-07-06 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 18,656 @ $0 | EDGAR |
| 2023-07-03 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 2,796 · Option exercise (M): 2,796 (derivative) @ $0 | EDGAR |
| 2023-06-23 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 15,490 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 18,285 @ $0 | EDGAR |
| 2023-04-03 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 2,041 @ $0 · Option exercise (M): 2,041 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Harpoon Therapeutics, Inc. (HARP) | Purchase (P): 10,000 @ $1,000 · Purchase (P): 2,994,305 (derivative) | EDGAR |
| 2023-01-05 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 11,099 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 1,197 · Option exercise (M): 1,197 (derivative) @ $0 | EDGAR |
| 2022-12-28 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 5,479 (derivative) @ $0 | EDGAR |
| 2022-09-27 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 2,796 (derivative) @ $0 | EDGAR |
| 2022-06-28 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 30,623 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 36,798 · Option exercise (M): 36,798 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 32,142 (derivative) @ $1.40 | EDGAR |
| 2022-06-17 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 647,059 (derivative) @ $0.01 | EDGAR |
| 2022-05-26 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 13,440 (derivative) @ $0 | EDGAR |
| 2022-03-29 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 17,955 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 6,242 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | Harpoon Therapeutics, Inc. (HARP) | Purchase (P): 235,294 @ $17 | EDGAR |
| 2021-08-04 | 4 | Rallybio Corp (RLYB) | Other (J): 1,993,911 · Purchase (P): 153,846 @ $13 · Purchase (P): 153,846 @ $13 · Other (J): 1,795,946 (derivative) · Other (J): 8,742,654 (derivative) · Other (J): 2,157,838 (derivative) · +1 more | EDGAR |
| 2021-06-25 | 4 | Iterum Therapeutics plc (ITRM) | Grant/award (A): 36,798 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4/A | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 4,658 (derivative) @ $0 | EDGAR |
| 2021-05-07 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 4,807 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-01 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs